HCMT
ECYT

Highland Capital Management (Texas)’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Highland Capital Management (Texas)’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-22,608
Closed -$402K – 371
2018
Q3 		$402K Buy
+22,608
New +$388K 0.02% 246
2017
Q1 		– Sell
-461,561
Closed -$1.18M – 341
2016
Q4 		$1.18M Sell
461,561
-3,645
-0.8% -$10.5K 0.06% 161
2016
Q3 		$1.44M Buy
465,206
+174,750
+60% +$545K 0.04% 180
2016
Q2 		$932K Sell
290,456
-152,200
-34% -$558K 0.04% 191
2016
Q1 		$1.37M Sell
442,656
-483,133
-52% -$1.58M 0.06% 164
2015
Q4 		$3.71M Buy
925,789
+228,420
+33% +$1.05M 0.12% 150
2015
Q3 		$3.19M Sell
697,369
-284,600
-29% -$1.49M 0.09% 167
2015
Q2 		$5.1M Sell
981,969
-17,346
-2% -$104K 0.1% 155
2015
Q1 		$6.26M Buy
999,315
+866,176
+651% +$5M 0.13% 135
2014
Q4 		$837K Buy
+133,139
New +$812K 0.03% 172
2014
Q2 		– Sell
-268,637
Closed -$6.4M – 320
2014
Q1 		$6.4M Buy
268,637
+176,191
+191% +$2.55M 0.26% 85
2013
Q4 		$987K Sell
92,446
-51,919
-36% -$573K 0.05% 117
2013
Q3 		$1.92M Buy
144,365
+23,456
+19% +$371K 0.12% 84
2013
Q2 		$1.59M Buy
+120,909
New +$1.63M 0.12% 83

Other funds holding ECYT

OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
CA
Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Highland Capital Management (Texas)'s ECYT Position: Q4 2018 in Review

Highland Capital Management (Texas) sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 22,608 shares — an estimated $402K sold.

Highland Capital Management (Texas) first reported a position in ECYT in Q2 2013 and held it in 14 quarters. The position peaked at $6.4M in Q1 2014. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

  • Highland Capital Management (Texas) reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 22,608 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $402K.
  • Highland Capital Management (Texas) first reported a position in Endocyte, Inc. Common Stock in Q2 2013 and held it in 14 quarters.
  • Highland Capital Management (Texas)'s Endocyte, Inc. Common Stock position peaked at $6.4M in Q1 2014.
  • 2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Highland Capital Management (Texas)'s 13F filing for Q4 2018, filed 13 Feb 2019.